Growth Metrics

NeuroPace (NPCE) Net Cash Flow (2020 - 2026)

NeuroPace has reported Net Cash Flow over the past 7 years, most recently at -$6.2 million for Q1 2026.

  • For Q1 2026, Net Cash Flow fell 145.56% year-over-year to -$6.2 million; the TTM value through Mar 2026 reached -$11.5 million, down 181.78%, while the annual FY2025 figure was $8.3 million, 280.43% up from the prior year.
  • Net Cash Flow for Q1 2026 was -$6.2 million at NeuroPace, down from $1.0 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $13.6 million in Q1 2025 and troughed at -$11.7 million in Q1 2022.
  • A 5-year average of -$215294.1 and a median of $12000.0 in 2022 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 15766.67% in 2023 and later crashed 4500.0% in 2024.
  • Year by year, Net Cash Flow stood at $860000.0 in 2022, then surged by 869.88% to $8.3 million in 2023, then tumbled by 122.67% to -$1.9 million in 2024, then skyrocketed by 155.21% to $1.0 million in 2025, then plummeted by 692.24% to -$6.2 million in 2026.
  • Business Quant data shows Net Cash Flow for NPCE at -$6.2 million in Q1 2026, $1.0 million in Q4 2025, and -$2.2 million in Q3 2025.